Details for New Drug Application (NDA): 062241
✉ Email this page to a colleague
NDA 062241 describes BACTOCILL, which is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in six NDAs. Additional details are available on the BACTOCILL profile page.
The generic ingredient in BACTOCILL is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
The generic ingredient in BACTOCILL is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
Summary for 062241
| Tradename: | BACTOCILL |
| Applicant: | Glaxosmithkline |
| Ingredient: | oxacillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062241
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
